Sign in
4

Changes in Ownership

ArriVent BioPharma, Inc. Filed Acc 0000902664-24-000903

10% owner bought 555,555 shares at $18.00 ($9,999,990)

  • 10% owner acquired 3,929,117 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
HILLHOUSE INVESTMENT MANAGEMENT, LTD. 10% owner 2024-01-30 Conversion +3,616,041 3,616,041 I
HILLHOUSE INVESTMENT MANAGEMENT, LTD. 10% owner 2024-01-30 Conversion +313,076 3,929,117 I
HILLHOUSE INVESTMENT MANAGEMENT, LTD. 10% owner 2024-01-30 Purchase +555,555 $18.00 $9,999,990 4,484,672 I
Derivatives
HILLHOUSE INVESTMENT MANAGEMENT, LTD. 10% owner 2024-01-30 Conversion · Series A Preferred Stock −55,000,000 0 I
HILLHOUSE INVESTMENT MANAGEMENT, LTD. 10% owner 2024-01-30 Conversion · Series B Preferred Stock −4,761,903 0 I
Open-market purchases · 555,555 sh · avg $18.00 · $9,999,990
Loading xslF345X05/ownership.xml…